Testing a method to improve patient adherence to the doctors treatment plan for topically treated psoriasis
Phase 1
- Conditions
- PsoriasisMedDRA version: 19.1Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Registration Number
- EUCTR2016-002143-42-DK
- Lead Sponsor
- Odense University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 134
Inclusion Criteria
Psoriasis patients aged 18-75 years diagnosed with mild-to moderate psoriasis.
Patients need to have a smartphone and basic user skills for the smartphone
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 106
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 28
Exclusion Criteria
aged under 18 and above 75 years, severe degrees of psoriasis, i.e. pustular and erythrodermic psoriasis, lack of smartphones and user skills for the smartphone.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Test if an app for smartphones can improve Medical adherence in psoriasis patients;Secondary Objective: Test if improved medical adherence can improve quality of life and reduce severity of disease;Primary end point(s): rate of secondary medical adherence;Timepoint(s) of evaluation of this end point: week 4.
- Secondary Outcome Measures
Name Time Method Secondary end point(s): DLQI (dermatology life quality index)<br><br>and<br><br>LS-GPA (lattice-system physician global assessment);Timepoint(s) of evaluation of this end point: baseline, week 4, week 8 and week 26